1. Home
  2. ENGN vs DBI Comparison

ENGN vs DBI Comparison

Compare ENGN & DBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENGN
  • DBI
  • Stock Information
  • Founded
  • ENGN 1999
  • DBI 1991
  • Country
  • ENGN Canada
  • DBI United States
  • Employees
  • ENGN N/A
  • DBI N/A
  • Industry
  • ENGN
  • DBI Clothing/Shoe/Accessory Stores
  • Sector
  • ENGN
  • DBI Consumer Discretionary
  • Exchange
  • ENGN Nasdaq
  • DBI Nasdaq
  • Market Cap
  • ENGN 293.1M
  • DBI 453.2M
  • IPO Year
  • ENGN N/A
  • DBI 1991
  • Fundamental
  • Price
  • ENGN $9.30
  • DBI $6.26
  • Analyst Decision
  • ENGN Strong Buy
  • DBI Hold
  • Analyst Count
  • ENGN 6
  • DBI 3
  • Target Price
  • ENGN $33.67
  • DBI $6.50
  • AVG Volume (30 Days)
  • ENGN 352.1K
  • DBI 2.6M
  • Earning Date
  • ENGN 09-10-2024
  • DBI 12-03-2024
  • Dividend Yield
  • ENGN N/A
  • DBI 3.19%
  • EPS Growth
  • ENGN N/A
  • DBI N/A
  • EPS
  • ENGN N/A
  • DBI N/A
  • Revenue
  • ENGN N/A
  • DBI $3,059,173,000.00
  • Revenue This Year
  • ENGN N/A
  • DBI $0.78
  • Revenue Next Year
  • ENGN N/A
  • DBI $3.19
  • P/E Ratio
  • ENGN N/A
  • DBI N/A
  • Revenue Growth
  • ENGN N/A
  • DBI N/A
  • 52 Week Low
  • ENGN $4.42
  • DBI $4.36
  • 52 Week High
  • ENGN $47.17
  • DBI $12.84
  • Technical
  • Relative Strength Index (RSI)
  • ENGN 76.66
  • DBI 47.05
  • Support Level
  • ENGN $6.66
  • DBI $5.68
  • Resistance Level
  • ENGN $7.44
  • DBI $6.27
  • Average True Range (ATR)
  • ENGN 0.75
  • DBI 0.34
  • MACD
  • ENGN 0.29
  • DBI -0.02
  • Stochastic Oscillator
  • ENGN 67.05
  • DBI 32.58

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

About DBI Designer Brands Inc.

Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment, and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.

Share on Social Networks: